Neuronoff
Company

Last deal

$2.2M

Amount

Grant

Stage

31.10.2019

Date

1

all rounds

$2.2M

Total amount

General

About Company
Neuronoff is developing the Injectrode™, an injectable metal electrode that stimulates nerves.

Industry

Sector :

Subsector :

Keywords :

founded date

01.01.2017

Number of employees

Company Type

For Profit

Last funding type

Grant

IPO status

Private

Description

The Injectrode™ is a novel medical device being developed by Neuronoff to enable clinicians to stimulate nerves for pain management and restore organ activity through neuromodulation. It is deployed via a small needle and offers a simple and effective solution for manufacturing the neuromodulation interface inside the body on various anatomical targets. Neuronoff's innovative approach has the potential to revolutionize pain management and improve organ function.
Contacts

Social url